_id

69105798ccc777a4e85d5697

Ticker

CVRX

Name

CVRx Inc

Exchange

NASDAQ

Address

9201 West Broadway Avenue, Minneapolis, MN, United States, 55445

Country

USA

Sector

Healthcare

Industry

Medical Devices

Currency

USD

Website

https://www.cvrx.com

Description

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Last Close

8.42

Volume

78421

Current Price

8.45

Change

0.35629453681709455

Last Updated

2025-11-29T12:01:52.683Z

Image

data:image/webp;base64,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

Ipo Date

2021-06-30T00:00:00.000Z

Market Cap

257121168

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.98825

Sentiment Sources

4

Rating

4.5714

Target Price

11.5

Strong Buy

5

Buy

1

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

14690000

Cost Of Revenue

1937000

Gross Profit

12753000

Operating Expenses

25021000

Operating Income

-12268000

Interest Expense

1480000

Pretax Income

-12873000

Net Income

-12870000

Eps

-0.4918115103153165

Dividends Per Share

-

Shares Outstanding

26210109

Income Tax Expense

-3000

EBITDA

-11200000

Operating Margin

-83.51259360108918

Total Other Income Expense Net

-605000

Cash

85124000

Short Term Investments

-

Receivables

8209000

Inventories

11394000

Total Current Assets

107890000

Property Plant Equipment

3409000

Total Assets

111325000

Payables

3628000

Short Term Debt

-

Long Term Debt

49453000

Total Liabilities

63271000

Equity

48054000

Depreciation

194000

Change In Working Capital

-1932000

Cash From Operations

-9709000

Capital Expenditures

295000

Cash From Investing

-295000

Cash From Financing

103000

Net Change In Cash

-95025000

PE

-

PB

4.601580490697964

ROE

-26.78236983393682

ROA

-11.560745564787783

FCF

-10004000

Fcf Percent

-0.6810074880871341

Piotroski FScore

1

Health Score

20

Deep Value Investing Score

3

Defensive Investing Score

6

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

1.5

Momentum Investing Score

3.5

Net Net Investing Score

1.5

Quality Investing Score

2

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

14690000

Quarters > 0 > income Statement > cost Of Revenue

1937000

Quarters > 0 > income Statement > gross Profit

12753000

Quarters > 0 > income Statement > operating Expenses

25021000

Quarters > 0 > income Statement > operating Income

-12268000

Quarters > 0 > income Statement > interest Expense

1480000

Quarters > 0 > income Statement > pretax Income

-12873000

Quarters > 0 > income Statement > net Income

-12870000

Quarters > 0 > income Statement > eps

-0.4918115103153165

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

26168562

Quarters > 0 > income Statement > income Tax Expense

-3000

Quarters > 0 > income Statement > EBITDA

-11200000

Quarters > 0 > income Statement > operating Margin

-83.51259360108918

Quarters > 0 > income Statement > total Other Income Expense Net

-605000

Quarters > 0 > balance Sheet > cash

85124000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

8209000

Quarters > 0 > balance Sheet > inventories

11394000

Quarters > 0 > balance Sheet > total Current Assets

107890000

Quarters > 0 > balance Sheet > property Plant Equipment

3409000

Quarters > 0 > balance Sheet > total Assets

111325000

Quarters > 0 > balance Sheet > payables

3628000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

49453000

Quarters > 0 > balance Sheet > total Liabilities

63271000

Quarters > 0 > balance Sheet > equity

48054000

Quarters > 0 > cash Flow > net Income

-12870000

Quarters > 0 > cash Flow > depreciation

194000

Quarters > 0 > cash Flow > change In Working Capital

-1932000

Quarters > 0 > cash Flow > cash From Operations

-9709000

Quarters > 0 > cash Flow > capital Expenditures

295000

Quarters > 0 > cash Flow > cash From Investing

-295000

Quarters > 0 > cash Flow > cash From Financing

103000

Quarters > 0 > cash Flow > net Change In Cash

-95025000

Quarters > 0 > ratios > PE

-0.4918115103153165

Quarters > 0 > ratios > PB

4.601580490697964

Quarters > 0 > ratios > ROE

-26.78236983393682

Quarters > 0 > ratios > ROA

-11.560745564787783

Quarters > 0 > ratios > FCF

-10004000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-0.6810074880871341

Quarters > 0 > health Score

20

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

13589000

Quarters > 1 > income Statement > cost Of Revenue

2139000

Quarters > 1 > income Statement > gross Profit

11450000

Quarters > 1 > income Statement > operating Expenses

25826000

Quarters > 1 > income Statement > operating Income

-14376000

Quarters > 1 > income Statement > interest Expense

1473000

Quarters > 1 > income Statement > pretax Income

-14739000

Quarters > 1 > income Statement > net Income

-14736000

Quarters > 1 > income Statement > eps

-0.5652188788628851

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

26071316

Quarters > 1 > income Statement > income Tax Expense

-3000

Quarters > 1 > income Statement > EBITDA

-13073000

Quarters > 1 > income Statement > operating Margin

-105.7914489660755

Quarters > 1 > income Statement > total Other Income Expense Net

-363000

Quarters > 1 > balance Sheet > cash

95025000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

7153000

Quarters > 1 > balance Sheet > inventories

11720000

Quarters > 1 > balance Sheet > total Current Assets

116145000

Quarters > 1 > balance Sheet > property Plant Equipment

3393000

Quarters > 1 > balance Sheet > total Assets

119564000

Quarters > 1 > balance Sheet > payables

3032000

Quarters > 1 > balance Sheet > short Term Debt

333000

Quarters > 1 > balance Sheet > long Term Debt

49392000

Quarters > 1 > balance Sheet > total Liabilities

61630000

Quarters > 1 > balance Sheet > equity

57934000

Quarters > 1 > cash Flow > net Income

-14736000

Quarters > 1 > cash Flow > depreciation

193000

Quarters > 1 > cash Flow > change In Working Capital

3631000

Quarters > 1 > cash Flow > cash From Operations

-7936000

Quarters > 1 > cash Flow > capital Expenditures

103000

Quarters > 1 > cash Flow > cash From Investing

-103000

Quarters > 1 > cash Flow > cash From Financing

392000

Quarters > 1 > cash Flow > net Change In Cash

-7643000

Quarters > 1 > ratios > PE

-0.5652188788628851

Quarters > 1 > ratios > PB

3.80264818931888

Quarters > 1 > ratios > ROE

-25.4358407843408

Quarters > 1 > ratios > ROA

-12.324780034123982

Quarters > 1 > ratios > FCF

-8039000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.5915814261535065

Quarters > 1 > health Score

20

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

12348000

Quarters > 2 > income Statement > cost Of Revenue

2036000

Quarters > 2 > income Statement > gross Profit

10312000

Quarters > 2 > income Statement > operating Expenses

23749000

Quarters > 2 > income Statement > operating Income

-13437000

Quarters > 2 > income Statement > interest Expense

1457000

Quarters > 2 > income Statement > pretax Income

-13771000

Quarters > 2 > income Statement > net Income

-13766000

Quarters > 2 > income Statement > eps

-0.531998763332818

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

25876000

Quarters > 2 > income Statement > income Tax Expense

-5000

Quarters > 2 > income Statement > EBITDA

-12130000

Quarters > 2 > income Statement > operating Margin

-108.8192419825073

Quarters > 2 > income Statement > total Other Income Expense Net

-334000

Quarters > 2 > balance Sheet > cash

102668000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

9012000

Quarters > 2 > balance Sheet > inventories

11672000

Quarters > 2 > balance Sheet > total Current Assets

126134000

Quarters > 2 > balance Sheet > property Plant Equipment

3429000

Quarters > 2 > balance Sheet > total Assets

129589000

Quarters > 2 > balance Sheet > payables

2751000

Quarters > 2 > balance Sheet > short Term Debt

290000

Quarters > 2 > balance Sheet > long Term Debt

49332000

Quarters > 2 > balance Sheet > total Liabilities

60229000

Quarters > 2 > balance Sheet > equity

69360000

Quarters > 2 > cash Flow > net Income

-13766000

Quarters > 2 > cash Flow > depreciation

184000

Quarters > 2 > cash Flow > change In Working Capital

-1699000

Quarters > 2 > cash Flow > cash From Operations

-12767000

Quarters > 2 > cash Flow > capital Expenditures

114000

Quarters > 2 > cash Flow > cash From Investing

-114000

Quarters > 2 > cash Flow > cash From Financing

9615000

Quarters > 2 > cash Flow > net Change In Cash

-3265000

Quarters > 2 > ratios > PE

-0.531998763332818

Quarters > 2 > ratios > PB

3.152425028835063

Quarters > 2 > ratios > ROE

-19.84717416378316

Quarters > 2 > ratios > ROA

-10.622815208080933

Quarters > 2 > ratios > FCF

-12881000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-1.0431648850016197

Quarters > 2 > health Score

26

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

15342000

Quarters > 3 > income Statement > cost Of Revenue

2299000

Quarters > 3 > income Statement > gross Profit

13043000

Quarters > 3 > income Statement > operating Expenses

23317000

Quarters > 3 > income Statement > operating Income

-10274000

Quarters > 3 > income Statement > interest Expense

1520000

Quarters > 3 > income Statement > pretax Income

-10722000

Quarters > 3 > income Statement > net Income

-10651000

Quarters > 3 > income Statement > eps

-0.4713618365259088

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

22596229

Quarters > 3 > income Statement > income Tax Expense

-71000

Quarters > 3 > income Statement > EBITDA

-9024000

Quarters > 3 > income Statement > operating Margin

-66.96649719723634

Quarters > 3 > income Statement > total Other Income Expense Net

-448000

Quarters > 3 > balance Sheet > cash

105933000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

9268000

Quarters > 3 > balance Sheet > inventories

12107000

Quarters > 3 > balance Sheet > total Current Assets

129813000

Quarters > 3 > balance Sheet > property Plant Equipment

3574000

Quarters > 3 > balance Sheet > total Assets

133414000

Quarters > 3 > balance Sheet > payables

2582000

Quarters > 3 > balance Sheet > short Term Debt

282000

Quarters > 3 > balance Sheet > long Term Debt

49273000

Quarters > 3 > balance Sheet > total Liabilities

62359000

Quarters > 3 > balance Sheet > equity

71055000

Quarters > 3 > cash Flow > net Income

-10651000

Quarters > 3 > cash Flow > depreciation

178000

Quarters > 3 > cash Flow > change In Working Capital

-281000

Quarters > 3 > cash Flow > cash From Operations

-8008000

Quarters > 3 > cash Flow > capital Expenditures

52000

Quarters > 3 > cash Flow > cash From Investing

-52000

Quarters > 3 > cash Flow > cash From Financing

13834000

Quarters > 3 > cash Flow > net Change In Cash

5772000

Quarters > 3 > ratios > PE

-0.4713618365259088

Quarters > 3 > ratios > PB

2.6871878833298144

Quarters > 3 > ratios > ROE

-14.989796636408418

Quarters > 3 > ratios > ROA

-7.983420030881316

Quarters > 3 > ratios > FCF

-8060000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.525355233998175

Quarters > 3 > health Score

31

Valuation > metrics > PE

-0.4918115103153165

Valuation > metrics > PB

4.601580490697964

Valuation > final Score

33.98419509302036

Valuation > verdict

53.4% Overvalued

Profitability > metrics > ROE

-26.78236983393682

Profitability > metrics > ROA

-11.928816387060895

Profitability > metrics > Net Margin

-0.8761061946902655

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.3166645856744497

Risk > metrics > Interest Coverage

-8.28918918918919

Risk > final Score

-3

Risk > verdict

High

Liquidity > metrics > Current Ratio

29.738147739801544

Liquidity > metrics > Quick Ratio

26.597574421168687

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

41.9735181068112

Prev Valuations > 1

48.47574971164937

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-9

Prev Risks > 1

11

Prev Risks > 2

21

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:22:43.896Z